Barclays
IBB icon

Barclays’s iShares Biotechnology ETF IBB Stock Holding History

Barclays’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.1M Sell
450,734
-221,207
-33% -$37.8M 0.02% 590
2025
Q4 		$113M Buy
671,941
+255,750
+61% +$41.5M 0.03% 447
2025
Q3 		$60.1M Buy
416,191
+26,032
+7% +$3.55M 0.01% 686
2025
Q2 		$49.4M Sell
390,159
-330,506
-46% -$40.6M 0.01% 715
2025
Q1 		$92.2M Buy
720,665
+41,948
+6% +$5.69M 0.03% 449
2024
Q4 		$89.7M Buy
678,717
+321,632
+90% +$45.2M 0.03% 432
2024
Q3 		$52M Buy
357,085
+315,994
+769% +$45.7M 0.01% 655
2024
Q2 		$5.64M Buy
41,091
+39,155
+2,022% +$5.23M ﹤0.01% 1465
2024
Q1 		$266K Sell
1,936
-1,461
-43% -$200K ﹤0.01% 3967
2023
Q4 		$461K Sell
3,397
-16,383
-83% -$2M ﹤0.01% 3923
2023
Q3 		$2.42M Sell
19,780
-114,105
-85% -$14.5M ﹤0.01% 1770
2023
Q2 		$17M Sell
133,885
-18,156
-12% -$2.36M 0.01% 781
2023
Q1 		$19.6M Buy
152,041
+149,413
+5,685% +$19.6M 0.01% 848
2022
Q4 		$345K Sell
2,628
-389,005
-99% -$50.3M ﹤0.01% 3535
2022
Q3 		$45.8M Buy
391,633
+263,247
+205% +$32.7M 0.05% 334
2022
Q2 		$15.1M Sell
128,386
-179,287
-58% -$21.3M 0.01% 834
2022
Q1 		$40.1M Sell
307,673
-8,092
-3% -$1.05M 0.03% 474
2021
Q4 		$48.2M Sell
315,765
-1,311,052
-81% -$203M 0.02% 594
2021
Q3 		$263M Buy
1,626,817
+235,319
+17% +$39.6M 0.12% 134
2021
Q2 		$228M Buy
1,391,498
+183,946
+15% +$28.3M 0.11% 153
2021
Q1 		$182M Sell
1,207,552
-152,571
-11% -$24.2M 0.1% 170
2020
Q4 		$206M Sell
1,360,123
-699,484
-34% -$100M 0.11% 140
2020
Q3 		$279M Sell
2,059,607
-542,762
-21% -$73.6M 0.17% 98
2020
Q2 		$356M Sell
2,602,369
-461,471
-15% -$58.8M 0.27% 53
2020
Q1 		$330M Sell
3,063,840
-54,913
-2% -$6.32M 0.26% 56
2019
Q4 		$376M Sell
3,118,753
-50,876
-2% -$5.68M 0.21% 74
2019
Q3 		$315M Buy
3,169,629
+3,011,766
+1,908% +$315M 0.2% 86
2019
Q2 		$17.2M Sell
157,863
-19,080
-11% -$2.03M 0.01% 1012
2019
Q1 		$19.8M Buy
176,943
+126,261
+249% +$13.8M 0.01% 859
2018
Q4 		$4.89M Buy
50,682
+30,951
+157% +$3.29M ﹤0.01% 1623
2018
Q3 		$2.41M Sell
19,731
-14,339
-42% -$1.69M ﹤0.01% 2662
2018
Q2 		$3.74M Sell
34,070
-191,637
-85% -$20.5M ﹤0.01% 1975
2018
Q1 		$24.1M Buy
225,707
+83,460
+59% +$9.25M 0.02% 760
2017
Q4 		$15.2M Buy
142,247
+18,662
+15% +$1.99M 0.01% 953
2017
Q3 		$13.7M Sell
123,585
-268,251
-68% -$28.7M 0.01% 857
2017
Q2 		$40.5M Sell
391,836
-573,576
-59% -$56.5M 0.04% 345
2017
Q1 		$94.4M Buy
965,412
+419,460
+77% +$40.2M 0.1% 148
2016
Q4 		$48.3M Buy
545,952
+34,641
+7% +$3.15M 0.05% 285
2016
Q3 		$49.3M Buy
511,311
+86,730
+20% +$8.25M 0.05% 258
2016
Q2 		$36.4M Buy
424,581
+52,500
+14% +$4.71M 0.05% 326
2016
Q1 		$32.2M Buy
372,081
+261,576
+237% +$23.4M 0.05% 339
2015
Q4 		$12.4M Sell
110,505
-534,561
-83% -$58M 0.02% 783
2015
Q3 		$65.2M Buy
645,066
+637,386
+8,299% +$76.5M 0.08% 215
2015
Q2 		$942K Buy
7,680
+7,500
+4,167% +$898K ﹤0.01% 2928
2015
Q1 		$21K Sell
180
-894,960
-100% -$98.7M ﹤0.01% 5800
2014
Q4 		$90.4M Sell
895,140
-1,473,645
-62% -$143M 0.09% 183
2014
Q3 		$216M Buy
2,368,785
+146,862
+7% +$12.9M 0.21% 63
2014
Q2 		$190M Sell
2,221,923
-876,546
-28% -$69.1M 0.2% 61
2014
Q1 		$244M Buy
3,098,469
+1,244,502
+67% +$104M 0.28% 49
2013
Q4 		$140M Sell
1,853,967
-240,543
-11% -$17.1M 0.14% 100
2013
Q3 		$146M Buy
2,094,510
+90,255
+5% +$5.91M 0.17% 76
2013
Q2 		$116M Buy
+2,004,255
New +$116M 0.14% 94

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barclays's IBB Position: Q1 2026 in Review

Barclays reduced its iShares Biotechnology ETF (IBB) stake by 33% in Q1 2026, selling an estimated $37.8M and leaving 450,734 shares worth $76.1M. The position accounts for 0.02% of the portfolio, ranked #590.

Barclays first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $376M in Q4 2019. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Barclays held 450,734 shares of iShares Biotechnology ETF worth $76.1M as of Q1 2026.
  • Barclays sold 221,207 iShares Biotechnology ETF shares in Q1 2026, an estimated $37.8M.
  • iShares Biotechnology ETF made up 0.02% of Barclays's portfolio in Q1 2026, its #590 holding.
  • Barclays first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Barclays's iShares Biotechnology ETF position peaked at $376M in Q4 2019.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.